Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications
Abstract Valerian root (Valeriana officinalis) is a popular and widely available herbal supplement used to treat sleeping disorders and insomnia. The herb’s ability to ameliorate sleep dysfunction may signify an unexplored anti-tumorigenic effect due to the connection between circadian factors and t...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ea22675247ee4e4f92a234176d4886ff |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ea22675247ee4e4f92a234176d4886ff |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ea22675247ee4e4f92a234176d4886ff2021-12-02T14:16:34ZValerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications10.1038/s41598-021-81620-x2045-2322https://doaj.org/article/ea22675247ee4e4f92a234176d4886ff2021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81620-xhttps://doaj.org/toc/2045-2322Abstract Valerian root (Valeriana officinalis) is a popular and widely available herbal supplement used to treat sleeping disorders and insomnia. The herb’s ability to ameliorate sleep dysfunction may signify an unexplored anti-tumorigenic effect due to the connection between circadian factors and tumorigenesis. Of particular interest are the structural similarities shared between valeric acid, valerian's active chemical ingredient, and certain histone deacteylase (HDAC) inhibitors, which imply that valerian may play a role in epigenetic gene regulation. In this study, we tested the hypothesis that the circadian-related herb valerian can inhibit breast cancer cell growth and explored epigenetic changes associated with valeric acid treatment. Our results showed that aqueous valerian extract reduced growth of breast cancer cells. In addition, treatment of valeric acid was associated with decreased breast cancer cell proliferation, migration, colony formation and 3D formation in vitro in a dose- and time-dependent manner, as well as reduced HDAC activity and a global DNA hypomethylation. Overall, these findings demonstrate that valeric acid can decrease the breast cancer cell proliferation possibly by mediating epigenetic modifications such as the inhibition of histone deacetylases and alterations of DNA methylation. This study highlights a potential utility of valeric acid as a novel HDAC inhibitor and a therapeutic agent in the treatment of breast cancer.Fengqin ShiYa LiRui HanAlan FuRonghua WangOlivia NusbaumQin QinXinyi ChenLi HouYong ZhuNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Fengqin Shi Ya Li Rui Han Alan Fu Ronghua Wang Olivia Nusbaum Qin Qin Xinyi Chen Li Hou Yong Zhu Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications |
description |
Abstract Valerian root (Valeriana officinalis) is a popular and widely available herbal supplement used to treat sleeping disorders and insomnia. The herb’s ability to ameliorate sleep dysfunction may signify an unexplored anti-tumorigenic effect due to the connection between circadian factors and tumorigenesis. Of particular interest are the structural similarities shared between valeric acid, valerian's active chemical ingredient, and certain histone deacteylase (HDAC) inhibitors, which imply that valerian may play a role in epigenetic gene regulation. In this study, we tested the hypothesis that the circadian-related herb valerian can inhibit breast cancer cell growth and explored epigenetic changes associated with valeric acid treatment. Our results showed that aqueous valerian extract reduced growth of breast cancer cells. In addition, treatment of valeric acid was associated with decreased breast cancer cell proliferation, migration, colony formation and 3D formation in vitro in a dose- and time-dependent manner, as well as reduced HDAC activity and a global DNA hypomethylation. Overall, these findings demonstrate that valeric acid can decrease the breast cancer cell proliferation possibly by mediating epigenetic modifications such as the inhibition of histone deacetylases and alterations of DNA methylation. This study highlights a potential utility of valeric acid as a novel HDAC inhibitor and a therapeutic agent in the treatment of breast cancer. |
format |
article |
author |
Fengqin Shi Ya Li Rui Han Alan Fu Ronghua Wang Olivia Nusbaum Qin Qin Xinyi Chen Li Hou Yong Zhu |
author_facet |
Fengqin Shi Ya Li Rui Han Alan Fu Ronghua Wang Olivia Nusbaum Qin Qin Xinyi Chen Li Hou Yong Zhu |
author_sort |
Fengqin Shi |
title |
Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications |
title_short |
Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications |
title_full |
Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications |
title_fullStr |
Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications |
title_full_unstemmed |
Valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications |
title_sort |
valerian and valeric acid inhibit growth of breast cancer cells possibly by mediating epigenetic modifications |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ea22675247ee4e4f92a234176d4886ff |
work_keys_str_mv |
AT fengqinshi valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications AT yali valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications AT ruihan valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications AT alanfu valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications AT ronghuawang valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications AT olivianusbaum valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications AT qinqin valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications AT xinyichen valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications AT lihou valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications AT yongzhu valerianandvalericacidinhibitgrowthofbreastcancercellspossiblybymediatingepigeneticmodifications |
_version_ |
1718391699385876480 |